The WHO’s global advisory committee on vaccine safety examined the data on Tuesday and reviewed reports of rare blood coagulation disorders in people who had received the shot, the agency has said.
Europe’s drug watchdog, which is due to report later on Thursday, is reviewing a small number of reports of bleeding, blood clots and low platelet counts in people who have received AstraZeneca’s vaccine.
Follow and connect with us on Twitter, Facebook, Linkedin